Risk not increased when results stratified by vaccination in second or third trimester, mRNA COVID-19 vaccine dose
Birth During COVID-19 Pandemic Impacts Infant Neurodevelopment
However, in utero exposure to maternal SARS-CoV-2 infection is not associated with significant differences in ASQ-3 domains at 6 months
Timing of COVID-19 Vaccination in Pregnancy Examined
Maternal anti-spike IgG levels detectable at delivery regardless of timing of vaccination; levels highest with early third-trimester vaccination
Obstetric Morbidities More Common in Women With COVID-19
Pregnant women diagnosed during the first wave of COVID-19 had higher frequency of maternal morbidities
COVID-19 Vaccination Not Linked to First-Trimester Miscarriage
Among women with miscarriage, adjusted odds ratios for COVID-19 vaccination in previous three and five weeks were 0.91 and 0.81
Delta Variant May Increase Risk for Poor Pregnancy Outcomes
Experts recommend COVID-19 vaccination for pregnant women to mitigate severe perinatal morbidity, mortality
Study IDs Pregnancy Complications in the U.S. Tied to the Pandemic
Higher risks for gestational hypertension, poor fetal growth, preeclampsia seen in pregnant women with commercial health insurance
Adverse Neonatal Outcomes Up for COVID-19-Positive Parturients
Composite neonatal adverse outcome incidence increased from healthy to asymptomatic to symptomatic women
COVID-19 Delta Variant Tied to More Hospitalizations in Pregnant Patients
One-fourth of pregnant patients diagnosed at a public Texas hospital between Aug. 29 and Sept. 4 admitted for severe illness
Cannabis Use in Pregnant Women Increased During the Pandemic
Rates of biochemically verified cannabis use early in pregnancy increased by 25 percent during versus 15 months before the pandemic